• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:202101021130040757   Update date: Feb. 23, 2025

Takekuma Munetaka

Takekuma Munetaka
Research theme for competitive and other funds  (1):
  • 2020 - 2023 子宮頸癌に対する本邦での低侵襲手術の再発リスク因子の検証
Papers (61):
  • Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, et al. Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology. 2024
  • Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, Guillermo Villacampa, Munetaka Takekuma, Ugo De Giorgi, Kristina Lindemann, Linn Woelber, Nicoletta Colombo, Linda Duska, et al. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. The Lancet. 2024. 403. 10421. 31-43
  • Munetaka Takekuma, Koji Matsuo, Shinya Matsuzaki, Mitsuya Ishikawa, Toyomi Satoh. Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors. Journal of Gynecologic Oncology. 2024. 35
  • Ayumi Taguchi, Kosuke Kato, Konan Hara, Akiko Furusawa, Yujiro Nakajima, Chihiro Ishizawa, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Muneaki Shimada, et al. Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group. Cancer Medicine. 2023
  • Eiji Kobayashi, Munetaka Takekuma, Takayuki Enomoto, Aikou Okamoto. Response to: Commentary on "Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2023. 33. 6. 1012-1012
more...
MISC (7):
  • 中村 俊昭, 田畑 務, 柳田 聡, 近藤 英司, 濱西 潤三, 原野 謙一, 長谷川 幸清, 平澤 猛, 堀 謙輔, 小宮山 慎一, et al. 前治療歴を有する高悪性度漿液性卵巣癌患者を対象としたニラパリブの国内第II相臨床試験の最終結果(The Final Results of a Japanese Phase 2 Study of Niraparib in Heavily Pretreated, HRd High-grade Serous Ovarian Cancer Patients). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 193-193
  • 長井 裕, 三上 幹男, 武隈 宗孝, 喜多川 亮, 長尾 昌二, 戸澤 晃子, 西尾 真, 小林 栄仁, 生水 真紀夫, 宮城 悦子, et al. 子宮頸部腺癌に対する同時化学放射線療法に関する多施設共同調査研究. 日本産科婦人科学会雑誌. 2019. 71. 臨増. S-324
  • Munetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, Wataru Kudaka, Koji Horie, Mariko Ikeda, Ayumi Shikama, Akira Mitsuhashi, Shoji Nagao, Shiro Suzuki, et al. Propensity score-matched analysis of systemic chemotherapy versus hysterectomy for patients with residual cervical disease after definitive radiotherapy/concurrent chemoradiotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2018. 36. 15
  • Yuka Kasamatsu, Munetaka Takekuma, Nobuhiro Kado, Emi Yoshioka, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Masakazu Abe, Yasuyuki Hirashima. The efficacy and safety of nedaplatin single therapy in 30 patients with platinum-resistant ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. 2017. 35
  • 野田 真永, 大野 達也, 馬屋原 健司, 武隈 宗孝, 平嶋 泰之, 宮城 悦子, 平田 英司, 田畑 勉, 青木 陽一, 若月 優, et al. 子宮 子宮頸がんの放射線療法・化学療法 局所進行子宮頸癌に対するCDDP/PTX同時併用化学放射線療法の多施設共同第II相試験. 日本癌治療学会学術集会抄録集. 2016. 54回. WS21-6
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page